Endocrinology and Metabolic Drug Advisory Committee

In a new report, analysts at JMP Securities focused on stocks and recent developments in the world of biotechnology. Overall, much of the sector has been under pressure recently from a negative market tone and “puzzling” Endocrinology and Metabolic Drug Advisory Committee (EMDAC)...